How Much Upside is Left in Actuate Therapeutics, Inc. (ACTU)? Wall Street Analysts Think 214.06%

Actuate Therapeutics, Inc. (ACTU) closed the last trading session at $6.9, gaining 4.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $21.67 indicates a 214.1% upside potential.The average comprises three short-term price targets ranging from a low of $20.00 to a high of $25.00, with a standard deviation of $2.89. While the lowest estimate indicates an increase of 189.9% from the ...